Ben Tre Pharmaceutical JSC (DBT) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.03x
Ben Tre Pharmaceutical JSC (DBT) has a Cash Flow Reinvestment Rate of 0.03x as of June 2020, reinvesting ₫1.27 Billion (capex ₫87.53 Million plus investments ₫-1.18 Billion) from operating cash flow of ₫37.04 Billion.
Reinvestment Rate
0.03x
(Capex + Investments) / Operating CF
Total Reinvested
₫1.27 Billion
Capex + Investments
Operating Cash Flow
₫37.04 Billion
VND
Capital Expenditures
₫87.53 Million
VND
Ben Tre Pharmaceutical JSC Cash Flow Reinvestment Rate (2016–2017)
Historical reinvestment intensity for Ben Tre Pharmaceutical JSC across 2 annual periods.
Annual Cash Flow Reinvestment Rate for Ben Tre Pharmaceutical JSC (2016–2017)
Year-by-year capital reinvestment analysis for Ben Tre Pharmaceutical JSC.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.80x | ₫40.69 Billion | ₫51.07 Billion | ₫9.02 Billion | ▼ -29.1% |
| 2016 | 1.12x | ₫36.73 Billion | ₫32.71 Billion | ₫4.50 Billion | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow